Daiichi Sankyo Co., Ltd. revenue for the last year amounted to 10.58 B USD, the most of which — 10.07 B USD — came from its highest performing source at the moment, Prescription Drugs, the year earlier bringing 9.08 B USD. The greatest contribution to the revenue figure was made by Japan — last year it brought Daiichi Sankyo Co., Ltd. 3.96 B USD, and the year before that — 4.02 B USD.